From a technical perspective, Beam Therapeutics Inc. (BEAM) is looking like an interesting pick, as it just reached a key level of support. BEAM's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that's formed when a stock's short-term moving average breaks above a longer-term moving average; the most common crossover involves the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.
Golden crosses have three key stages that investors look out for. It starts with a downtrend in a stock's price that eventually bottoms out, followed by the stock's shorter moving average crossing over its longer moving average and triggering a trend reversal. The final stage is when a stock continues the upward climb to higher prices.
This kind of chart pattern is the opposite of a death cross, which is a technical event that suggests future bearish price movement.
BEAM has rallied 6.8% over the past four weeks, and the company is a #2 (Buy) on the Zacks Rank at the moment. This combination indicates BEAM could be poised for a breakout.
The bullish case only gets stronger once investors take into account BEAM's positive earnings outlook for the current quarter. There have been 1 upward revision compared to none lower over the past 60 days, and the Zacks Consensus Estimate has moved up as well.

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on BEAM for more gains in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Nov-10 | |
| Nov-10 |
Beam Therapeutics to seek approval of SCD cell therapy after trial success
BEAM -6.92%
Clinical Trials Arena
|
| Nov-10 | |
| Nov-04 | |
| Nov-03 | |
| Oct-31 | |
| Oct-27 | |
| Oct-27 | |
| Oct-13 | |
| Sep-29 | |
| Sep-28 | |
| Sep-24 | |
| Sep-22 | |
| Sep-08 | |
| Sep-01 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite